Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00944476 · ClinicalTrials.gov registry record
Application of Magnetic Resonance Fat-Free Imaging
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Terminated
- Registry status
- 2
- Enrollment target
NCT00944476: Clinical Trial study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00944476 is a clinical trial that was terminated before completion, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00944476 was terminated before completion, sponsored by Memorial Sloan Kettering Cancer Center.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Magnetic resonance imaging (MRI) is presently the best study for assessing the size and extent of the patient's sarcoma. Many sarcomas contain fat that can interfere with the accuracy of sarcoma detection. The investigators have developed a new MRI method that can suppress all the fat signals in the patient's tumor and this may improve the investigators' ability to see the patient's sarcoma. The purpose of this study is to determine if the investigators' new fat-free imaging methods provides them with images that are better than, equal to, or worse than those images obtained by standard MRI methods. This study may help the investigators develop a more accurate MRI examination.
Interventions
- PROCEDURE Fat-free MRI images utilizing standard magnetization, Questionnaire before the MRI exam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00944476
The ClinicalTrials.gov registry entry for NCT00944476 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fat-free MRI images utilizing standard magnetization, Questionnaire before the MRI exam is the first listed.
NCT00944476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00944476 about?
NCT00944476 is a clinical study titled "Application of Magnetic Resonance Fat-Free Imaging". Magnetic resonance imaging (MRI) is presently the best study for assessing the size and extent of the patient's sarcoma. Many sarcomas contain fat that can interfere with the accuracy of sarcoma detection. The investigators have developed a new MRI method that can suppress all the fat signals in the...
What is the current status of trial NCT00944476?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2009-07.
What interventions are being tested in trial NCT00944476?
The interventions under investigation include: Fat-free MRI images utilizing standard magnetization, Questionnaire before the MRI exam (PROCEDURE).
Who is sponsoring clinical trial NCT00944476?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.